Rilonacept (Arcalyst ®) in the Treatment of Subacromial Bursitis

NCT01830699 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

33

Enrollment

FED

Sponsor class

Conditions

Subacromial Bursitis

Interventions

DRUG: Rilonacept
DRUG: Corticosteroid

Sponsor

Keesler Air Force Base Medical Center